Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Saito, T., Owen, D
Figure 3: The average number of crossing into the target quadrant in each of the four different experimental groups included in the first part of the study
Gastroenterology Hepatology and Digestive Endoscopy suggests that 70 percent of people who frequently take anthraquinone laxatives will develop melanosis coli, often within just a few months of use
doi: 10.3389/fendo.2019.00155 129 DuarteAICandeiasECorreiaSCSantosRXCarvalhoCCardosoSet al
| Co-prescribed Drug | Interaction Pathway | Effect on Co-Drug | Severity | Clinical Action | |---|---|---|---|---| | Warfarin | Hepatic CYP2C9 induction (GCGR) | Reduced anticoagulant effect
